"Cloud computing" read the Mysteries of genes

"Everyone is a book, we can only read a few of them before, and now we have the ability to read a whole book." "Cloud computing and large data technology progress and popularization, so that the medical health of the Connaught Xiaofi director of the division, have to say this words of the emboldened."

Connaught Tatsu is a large data transport in the field of medical and health High-tech Enterprises, the major genomics technology, the three operators settled in Guizhou, Guiyang has been listed as the focus of technology promotion

1. Finding diseases faster and earlier

In the field of health, genomics has great potential, not only to provide new diagnoses and treatments for some diseases, but also to assess the likelihood of recurrence and the effects of chemotherapy, to help doctors get more information about their treatment and to personalize their care.

Xiaofi Introduction, although genomics is good, but the amount of genomic data is very large, light a person's genome has 3 g size, equivalent to more than 3,000 photos, tens of thousands of novels. In recent years, as the cost of gene sequencing has been decreasing, the number of data generated has become more and more massive, before the advent of cloud computing, it is difficult to read these data, "this book" can not see the end. Now, many companies and research institutions like the company are using advanced algorithms and cloud computing to speed up gene sequencing, making it faster, easier and cheaper to find the disease.

An example of an early cancer risk screening technique through sequencing technology, the genes of the tumor-related genes and the subjects were scanned, then the data were compared in the database, which combined with the patient's health survey information, could give further risk assessment and life advice. "This series of tests, only need to extract 5 ml of blood can be." Xiaofi said that, compared with the traditional method of physical examination, the tumor-related gene can be detected at one time to 110, not only to detect known mutations, but also to detect unknown gene mutation sites.

2. Building Private Health management

Under the framework of large data technology, individualized medication instruction, single gene genetic disease screening and individual genome testing are becoming the reality. In Xiaofi's view, genetic sequencing will be able to comprehensively analyze the link between genetic variability and disease, speeding up the transformation of clinical applications of basic medical research.

"When you're 50 years old, you're 2.13 times times more likely to have cervical spondylosis than your peers," he said. "The big data will bring more opportunities for individualized care," Xiaofi. Through a detailed interpretation of the individual genome information, a comprehensive examination and evaluation of a variety of diseases and other important genetic data, it will be possible to predict their physical condition over the years, providing health counseling and digital health management on the basis of which is a rare asset for patients ' health.

For doctors, every patient he faces has individual differences, and if treated in the same way, the effect is often not guaranteed. For example, the same is the treatment of colds, the market can choose as many as dozens of kinds of drugs, for different patients, which effect is better, which side effect is the lowest, genome calculation can provide the correct answer.

For pharmaceutical companies, it is also possible to predict which drugs are effective for specific mutant patients, to identify the genetic characteristics of the individual in the drug metabolism, to seek disease-related genes, to make more scientific and accurate diagnosis and medication decisions for patients, and to improve the efficacy of drugs to a greater extent.

3. Identify the causes of cancer

At present, the Connaught Tatsu and the PLA General Hospital signed the "Joint Research Center for genome-Building" cooperation agreement, will use cloud computing technology and large data applications, leukemia comprehensive genetic analysis, accelerate the clinical application of basic medical research transformation.

"Simply to find the difference. "Xiaofi said, the next generation of genetic sequencing is to compare normal cells with cancer cells to find out the difference, which is likely to be the cause of cancer, or a key factor in survival and growth, and if it can be curbed, it could cure cancer.

In addition, there will be the development of many genomics techniques, such as exon sequencing and microbial genome sequencing. Guiyang is also listed as one of the key cities for their technology promotion. "The three major operators, ZTE and other large data-related enterprises have begun to gather in Guiyang, we have this consideration." "Xiaofi said, Connaught Tatsu intends to work with Guiyang medical institutions docking, the early stage of genetic testing technology to promote to Guiyang, the conditions will be sent to send scientific research team Guiyang to establish genetic testing technology research and Development Center.

RELATED LINKS

Customized personal genetic files

In the future, patients to do their own 24-hour heart rate monitoring, blood glucose index detection will become very feasible. Xiaofi even predicts that with the infiltration of large data in the medical field, "we can expect to have a copy of our genetic files in the future." "This will allow patients to grasp their health status, easily seek treatment, and achieve better results."